AMZN
Amazon.com, Inc.
AMZN has a slight edge over ARCO overall, supported by stronger modeled upside and lower modeled downside.
ARCO
Arcos Dorados Holdings Inc.
ARCO offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
ARCO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Under pressure |
ARCO's revenue and profitability are currently healthy, and its cash flow is stable, but its balance sheet is under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
ARCO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 5.8x | $7.00 | — |
| Cheap | 7.8x | $9.45 | +35% |
| Fair | 11x | $13.88 | +98% |
| Expensive | 19x | $23.55 | +236% |
Historical ranges are pointers, not guarantees.
ARCO has the edge over AMZN in the historical PE scenario, which offers more potential upside but is not a forecast.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
ARCO Forward outlook
There aren't enough analyst estimates for ARCO to show an outlook.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over ARCO on earnings, with more consistent year-over-year improvement.
ARCO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $1.21 | +92% |
| Q1 2026 | $1.11 | +71% |
| Q4 2025 | $1.01 | +40% |
| Q3 2025 | $1.17 | +67% |
| Q2 2025 | $0.63 | -44% |
| Q1 2025 | $0.65 | -42% |
| Q4 2024 | $0.72 | -38% |
| Q3 2024 | $0.70 | -40% |
ARCO earned $1.21 per share over the past year, up 92% from the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over ARCO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over ARCO on profitability, with a higher operating margin.
ARCO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $1.3B | +14% |
| Q1 2026 | $1.2B | +13% |
| Q4 2025 | $1.3B | +11% |
| Q3 2025 | $1.2B | +5.2% |
| Q2 2025 | $1.1B | +2.8% |
| Q1 2025 | $1.1B | -0.4% |
| Q4 2024 | $1.1B | -2.7% |
| Q3 2024 | $1.1B | +0.8% |
ARCO's revenue has grown year over year for five quarters in a row: $1.3B last quarter, up 14% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 5.9% | +0.4 points |
| Q1 2026 | 4.7% | +0.5 points |
| Q4 2025 | 7.5% | -1.5 points |
| Q3 2025 | 12% | +5.3 points |
| Q2 2025 | 5.5% | -1.2 points |
| Q1 2025 | 4.2% | -2.1 points |
| Q4 2024 | 9% | +2 points |
| Q3 2024 | 7% | -1 points |
ARCO's operating margin was 5.9% last quarter, about level with the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
ARCO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $56.4M | +257% |
| Q1 2026 | -$18.7M | +$43.5M |
| Q4 2025 | $27.2M | +46% |
| Q3 2025 | $30.4M | +421% |
| Q2 2025 | $15.8M | +$30.4M |
| Q1 2025 | -$62.2M | +$8.4M |
| Q4 2024 | $18.6M | +65% |
| Q3 2024 | $5.8M | -87% |
ARCO has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
ARCO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | 0% | -- |
| 3 years | 0% | +37.2K shares |
| 5 years | +0.1% | +303K shares |
| Available history | +0.4% | +919K shares |
ARCO has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
ARCO hasn't bought back shares in the past year.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over ARCO on leverage, with a lower net debt burden relative to earnings.
ARCO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 3.0x | Elevated |
| Q1 2026 | 3.1x | Elevated |
| Q4 2025 | 3.2x | Elevated |
| Q3 2025 | 3.3x | Elevated |
| Q2 2025 | 4.0x | Elevated |
| Q1 2025 | 3.8x | Elevated |
| Q4 2024 | 3.3x | Elevated |
| Q3 2024 | 3.4x | Elevated |
ARCO's net debt is about 3.0 years of its operating earnings (EBITDA), down from 4.0 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
ARCO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 12.7 | Oversold |
ARCO's weekly RSI is 40 (neutral) and its Stochastic is 13 (oversold).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
ARCO PE vs Consumer Cyclical Sector
| Metric | ARCO | Sector median | Relative |
|---|---|---|---|
| PE | 5.8x | 18x | 68% below |
| PE % | 1 | 47 | 46 pts below |
ARCO has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over ARCO on trend strength, trading above more of its moving averages.
ARCO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $7.36 | 4.9% below |
| 20 week MA | $7.80 | 10% below |
| 50 week MA | $8.05 | 13% below |
| 100 week MA | $7.74 | 9.6% below |
| 200 week MA | $8.75 | 20% below |
ARCO is in a downtrend: it's below all five of its weekly moving averages, and 20% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over ARCO on returns for 2026, with the stronger performance.
ARCO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $8.18 | $4.93 | -40% |
| 2021 | $4.93 | $5.33 | +8.1% |
| 2022 | $5.33 | $8.32 | +56% |
| 2023 | $8.32 | $12.7 | +53% |
| 2024 | $12.7 | $7.29 | -43% |
| 2025 | $7.29 | $7.37 | +1.1% |
| 2026 YTD | $7.37 | $7.00 | -5% |
ARCO has finished higher in four of the last six years, two of them by more than 50%. It's down 5% so far in 2026.